List of works - Jan Mollenhauer

A variant form of the human deleted in malignant brain tumor 1 (DMBT1) gene shows increased expression in inflammatory bowel diseases and interacts with dimeric trefoil factor 3 (TFF3).

scientific article

Allelic variants of CAMTA1 and FLJ10737 within a commonly deleted region at 1p36 in neuroblastoma

scientific article

Application of a global proteomic approach to archival precursor lesions: deleted in malignant brain tumors 1 and tissue transglutaminase 2 are upregulated in pancreatic cancer precursors

scientific article published on 13 October 2008

CRP-ductin, the mouse homologue of gp-340/deleted in malignant brain tumors 1 (DMBT1), binds gram-positive and gram-negative bacteria and interacts with lung surfactant protein D

scientific article

Carcinogen inducibility in vivo and down-regulation of DMBT1 during breast carcinogenesis

scientific article

Characterization of FIBCD1 as an acetyl group-binding receptor that binds chitin

scientific article

Classification of breast cancer subtypes by combining gene expression and DNA methylation data.

scientific article

Clonal expansion and linear genome evolution through breast cancer progression from pre-invasive stages to asynchronous metastasis

scientific article published on March 2015

Comprehensive analysis of high-throughput screens with HiTSeekR

scientific article

Construction of biosensor systems for determining the pathophysiological potential of carrageenan variants

scientific article

DMBT1 expression in biliary carcinogenesis with correlation of clinicopathological data.

scientific article

DMBT1 functions as pattern-recognition molecule for poly-sulfated and poly-phosphorylated ligands

scientific article

DMBT1 promotes basal and meconium-induced nitric oxide production in human lung epithelial cells in vitro

scientific article published on 15 September 2016

Deleted in Malignant Brain Tumors 1 (DMBT1) is present in hyaline membranes and modulates surface tension of surfactant

scientific article

Deleted in malignant brain tumors 1 (DMBT1) elicits increased VEGF and decreased IL-6 production in type II lung epithelial cells

scientific article published on 8 April 2015

Development of a cell-based bioassay for phospholipase A2-triggered liposomal drug release

scientific article

Differentially expressed genes in pancreatic ductal adenocarcinomas identified through serial analysis of gene expression

scientific article

Ectopic expression of cancer/testis antigen SSX2 induces DNA damage and promotes genomic instability.

scientific article

Efficient Management of High-Throughput Screening Libraries with SAVANAH

Efficient sample tracking with OpenLabFramework

scientific article

Evaluation of cobalt-labeled octreotide analogs for molecular imaging and auger electron-based radionuclide therapy

scientific article

Evaluation of somatostatin and nucleolin receptors for therapeutic delivery in non-small cell lung cancer stem cells applying the somatostatin-analog DOTATATE and the nucleolin-targeting aptamer AS1411.

scientific article

Expression of acyl-CoA synthetase 5 reflects the state of villus architecture in human small intestine

scientific article published in February 2004

GAGE cancer-germline antigens are recruited to the nuclear envelope by germ cell-less (GCL).

scientific article

Genetic mapping in mice identifies DMBT1 as a candidate modifier of mammary tumors and breast cancer risk

scientific article

Genetic variation of Aflatoxin B1 aldehyde reductase genes (AFAR) in human tumour cells

scientific article

Genomic Analyses of Breast Cancer Progression Reveal Distinct Routes of Metastasis Emergence.

scientific article

High DMBT1 concentrations in breast milk correlate with increased risk of infection in preterm and term neonates

scientific article

Identification of the bacteria-binding peptide domain on salivary agglutinin (gp-340/DMBT1), a member of the scavenger receptor cysteine-rich superfamily

scientific article

KeyPathwayMinerWeb: online multi-omics network enrichment.

scientific article published on 5 May 2016

Microarray R-based analysis of complex lysate experiments with MIRACLE.

scientific article published on September 2014

OpenLabNotes--An Electronic Laboratory Notebook Extension for OpenLabFramework

scientific article published on 6 October 2015

Protein-based nanotoxicology assessment strategy

scientific article published on 4 January 2017

Rare mutations of the DMBT1 gene in human astrocytic gliomas

scientific article

Regulation of DMBT1 via NOD2 and TLR4 in intestinal epithelial cells modulates bacterial recognition and invasion

scientific article

Review: Gp-340/DMBT1 in mucosal innate immunity

scientific article published on 23 April 2010

Robust de novo pathway enrichment with KeyPathwayMiner 5.

scientific article published on 28 June 2016

SSX2 is a novel DNA-binding protein that antagonizes polycomb group body formation and gene repression.

scientific article published on 23 September 2014

Salivary agglutinin/glycoprotein-340/DMBT1: a single molecule with variable composition and with different functions in infection, inflammation and cancer

scientific article published on December 2007

Synthesis and evaluation of cardiac glycoside mimics as potential anticancer drugs.

scientific article published on 16 February 2011

Systematic screening of isogenic cancer cells identifies DUSP6 as context-specific synthetic lethal target in melanoma

scientific article

The conserved scavenger receptor cysteine-rich superfamily in therapy and diagnosis

scientific article

The pattern recognition molecule deleted in malignant brain tumors 1 (DMBT1) and synthetic mimics inhibit liposomal nucleic acid delivery.

scientific article published on 7 September 2010

The recognition unit of FIBCD1 organizes into a noncovalently linked tetrameric structure and uses a hydrophobic funnel (S1) for acetyl group recognition

scientific article

The scavenging capacity of DMBT1 is impaired by germline deletions

scientific article published on 31 March 2017

List of works by Jan Mollenhauer

A variant form of the human deleted in malignant brain tumor 1 (DMBT1) gene shows increased expression in inflammatory bowel diseases and interacts with dimeric trefoil factor 3 (TFF3).

Allelic variants of CAMTA1 and FLJ10737 within a commonly deleted region at 1p36 in neuroblastoma

Application of a global proteomic approach to archival precursor lesions: deleted in malignant brain tumors 1 and tissue transglutaminase 2 are upregulated in pancreatic cancer precursors

CRP-ductin, the mouse homologue of gp-340/deleted in malignant brain tumors 1 (DMBT1), binds gram-positive and gram-negative bacteria and interacts with lung surfactant protein D

Carcinogen inducibility in vivo and down-regulation of DMBT1 during breast carcinogenesis

Characterization of FIBCD1 as an acetyl group-binding receptor that binds chitin

Classification of breast cancer subtypes by combining gene expression and DNA methylation data.

Clonal expansion and linear genome evolution through breast cancer progression from pre-invasive stages to asynchronous metastasis

Comprehensive analysis of high-throughput screens with HiTSeekR

Construction of biosensor systems for determining the pathophysiological potential of carrageenan variants

DMBT1 expression in biliary carcinogenesis with correlation of clinicopathological data.

DMBT1 functions as pattern-recognition molecule for poly-sulfated and poly-phosphorylated ligands

DMBT1 promotes basal and meconium-induced nitric oxide production in human lung epithelial cells in vitro

Deleted in Malignant Brain Tumors 1 (DMBT1) is present in hyaline membranes and modulates surface tension of surfactant

Deleted in malignant brain tumors 1 (DMBT1) elicits increased VEGF and decreased IL-6 production in type II lung epithelial cells

Development of a cell-based bioassay for phospholipase A2-triggered liposomal drug release

Differentially expressed genes in pancreatic ductal adenocarcinomas identified through serial analysis of gene expression

Ectopic expression of cancer/testis antigen SSX2 induces DNA damage and promotes genomic instability.

Efficient Management of High-Throughput Screening Libraries with SAVANAH

Efficient sample tracking with OpenLabFramework

Evaluation of cobalt-labeled octreotide analogs for molecular imaging and auger electron-based radionuclide therapy

Evaluation of somatostatin and nucleolin receptors for therapeutic delivery in non-small cell lung cancer stem cells applying the somatostatin-analog DOTATATE and the nucleolin-targeting aptamer AS1411.

Expression of acyl-CoA synthetase 5 reflects the state of villus architecture in human small intestine

GAGE cancer-germline antigens are recruited to the nuclear envelope by germ cell-less (GCL).

Genetic mapping in mice identifies DMBT1 as a candidate modifier of mammary tumors and breast cancer risk

Genetic variation of Aflatoxin B1 aldehyde reductase genes (AFAR) in human tumour cells

Genomic Analyses of Breast Cancer Progression Reveal Distinct Routes of Metastasis Emergence.

High DMBT1 concentrations in breast milk correlate with increased risk of infection in preterm and term neonates

Identification of the bacteria-binding peptide domain on salivary agglutinin (gp-340/DMBT1), a member of the scavenger receptor cysteine-rich superfamily

KeyPathwayMinerWeb: online multi-omics network enrichment.

Microarray R-based analysis of complex lysate experiments with MIRACLE.

OpenLabNotes--An Electronic Laboratory Notebook Extension for OpenLabFramework

Protein-based nanotoxicology assessment strategy

Rare mutations of the DMBT1 gene in human astrocytic gliomas

Regulation of DMBT1 via NOD2 and TLR4 in intestinal epithelial cells modulates bacterial recognition and invasion

Review: Gp-340/DMBT1 in mucosal innate immunity

Robust de novo pathway enrichment with KeyPathwayMiner 5.

SSX2 is a novel DNA-binding protein that antagonizes polycomb group body formation and gene repression.

Salivary agglutinin/glycoprotein-340/DMBT1: a single molecule with variable composition and with different functions in infection, inflammation and cancer

Synthesis and evaluation of cardiac glycoside mimics as potential anticancer drugs.

Systematic screening of isogenic cancer cells identifies DUSP6 as context-specific synthetic lethal target in melanoma

The conserved scavenger receptor cysteine-rich superfamily in therapy and diagnosis

The pattern recognition molecule deleted in malignant brain tumors 1 (DMBT1) and synthetic mimics inhibit liposomal nucleic acid delivery.

The recognition unit of FIBCD1 organizes into a noncovalently linked tetrameric structure and uses a hydrophobic funnel (S1) for acetyl group recognition

The scavenging capacity of DMBT1 is impaired by germline deletions